Gulfo Joseph V 4
4 · MELA SCIENCES, INC. /NY · Filed Nov 2, 2011
Insider Transaction Report
Form 4
Gulfo Joseph V
DirectorCEO & President
Transactions
- Award
Stock Option
2011-11-01+540,000→ 900,000 totalExercise: $3.75From: 2011-11-01Exp: 2018-10-10→ Common Stock (540,000 underlying)
Footnotes (1)
- [F1]The option grant was made by the Issuer's Board of Directors on October 10, 2008, with vesting of the options conditioned upon approval by the U.S. Food and Drug Administration ("FDA") of the Issuer's pre-market approval ("PMA") application for MelaFind. The FDA approved the MelaFind PMA on November 1, 2011. In accordance with the SEC's rules and regulations, the option grant is now being reported by the Reporting Person; however, the option grant has already been reported by the Issuer in its reports previously filed with the SEC.